-
The Health Impact of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab Treatment for High-Risk Early Stage Triple-Negative Breast Cancer (eTNBC) in Türkiye
Sep 9, 2025, 16:22 PM -
Challenges in PICO Definition for HTDs: Lessons From Durvalumab Exercise
Sep 9, 2025, 16:22 PM -
Inter-Version Comparison of the Boston Carpal Tunnel Questionnaire: A Clinical Validation Study of the Decision Tree-Based Version
Sep 9, 2025, 16:22 PM -
Are We There Yet? Mapping Member State Readiness for Local Implementation of the EU Health Technology Assessment (HTA) Regulation
Sep 9, 2025, 16:22 PM -
Bridging the Gap: What Spain Can Learn From European Leaders in Digital Therapy Reimbursement
Sep 9, 2025, 16:22 PM -
Challenges and Opportunities in the Dutch Lock Procedure Improving Access and Reimbursement Timelines for Cell and Gene Therapies in the Netherlands
Sep 9, 2025, 16:22 PM -
Structural Uncertainty (SU) in Model-Based Economics Appraisal (MBEA): A Document Review of the French National Authority for Health (HAS)
Sep 9, 2025, 16:22 PM -
Sex Differences in Chronic Hand Eczema (CHE) Triggering Factors: Comorbidities, Lifestyle, and Exposures Findings From a Multinational Study in Six Countries
Sep 9, 2025, 16:22 PM -
Time to and Time in Better Health States With Sotatercept for Pulmonary Arterial Hypertension: A Modeling Study
Sep 9, 2025, 16:22 PM -
Pain and Fatigue Assessment and Evaluation in Oncology Trials
Sep 9, 2025, 16:22 PM -
AI for Precision Oncology Evidence: Case Study Research From British Columbia, Canada
Sep 9, 2025, 16:22 PM -
Cost-Savings Analysis of Fitusiran Prophylaxis: Reducing Breakthrough Bleeding Treatment Expenditure in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
A Review of Information Uncertainty in Oncology Treatment Preferences
Sep 9, 2025, 16:22 PM -
Gender Differences in the Economic Burden of Alcohol Use in Belgium
Sep 9, 2025, 16:22 PM -
Disability Resource Utilization and Caregiver Support Among a Real-World Sample of Patients With Transthyretin Amyloidosis With Polyneuropathy
Sep 9, 2025, 16:22 PM -
Comorbidities and Comedication Among Individuals in Treatment for ADHD: A Danish Nationwide Study
Sep 9, 2025, 16:22 PM -
Comparative Analysis of Reimbursement Decisions for Advanced Oncology Combination Therapies in England and Japan
Sep 9, 2025, 16:22 PM -
Trends in Receipt of Preventive Healthcare Services from 2020-2024: US Electronic Health Records (EHR) Database Analysis of 118 Million Patients
Sep 9, 2025, 16:22 PM -
Real-World Burden of Illness in Patients With ER+/HER2- ABC Receiving Second-Line Treatment: Interim Results of Longitudinal Health Utility Data
Sep 9, 2025, 16:22 PM -
Quantifying the Fiscal Value of Prevention Programs for Depression
Sep 9, 2025, 16:22 PM
